ArticleRevista Cuidarte
Sit-to-stand test as a complementary assessment in patients with cardiovascular disease.
Article in Revista Cuidarte. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The 1-Minute Sit to Stand Test (STS1) has gained relevance as a simple, safe, and functional test in patients with cardiovascular disease, especially in settings where the 6-Minute Walk Test (6MWT) is not feasible. Its usefulness in assessing lower-extremity muscle strength makes it a complementary tool of increasing interest that can strengthen functional assessment batteries in this population. Objective: To assess the correlation between the 6MWT and the STS1 as complementary tools in the functional assessment of patients with cardiovascular disease. Materials and Methods: Descriptive, correlational, cross-sectional study conducted in 45 patients enrolled in a cardiac rehabilitation program at a quaternary care clinic in Cali, Colombia. The 6MWT and STS1 were administered, assessing physiological variables and physical performance variables. Pearson's correlation coefficient was used for bivariate analysis. Results: The mean age was 62.97 ± 12.58 years; 64.4% were women. Coronary artery disease was the most common diagnosis (73.3%). A moderate positive correlation was found between the distance walked in the 6MWT and the number of repetitions in the STS1 (r=0.610; p<0.001). The 6MWT elicited a greater increase in heart rate (final: 112.7 ± 18.1), whereas the STS1 had a greater impact on systolic blood pressure (final SBP: 146.8 ± 27.9; p<0.001). Discussion: The results are consistent with studies in other populations and support the use of STS1 as a valid functional assessment option. Conclusion: The STS1 complements the 6MWT in the functional assessment of patients with cardiovascular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.